Humanin and the Receptors for Humanin

Overview

Journal Mol Neurobiol

Specialties Molecular Biology
Neurology

Date 2009 Dec 10

PMID 19997871

Citations 26

Authors

Masaaki Matsuoka

Yuichi Hashimoto

Affiliations

Soon will be listed here.

Abstract

Alzheimer's disease (AD) is a prevalent dementia-causing neurodegenerative disease. Neuronal death is closely linked to the progression of AD-associated dementia. Accumulating evidence has established that a 24-amino-acid bioactive peptide, Humanin, protects neurons from AD-related neuronal death. A series of studies using various murine AD models including familial AD gene-expressing transgenic mice have shown that Humanin is effective against AD-related neuronal dysfunction in vivo. Most recently, it has been shown that Humanin inhibits neuronal cell death and dysfunction by binding to a novel IL-6-receptor-related receptor(s) on the cell surface involving CNTFRalpha, WSX-1, and gp130. These findings suggest that endogenous Humanin [or a Humanin-like substance(s)] may suppress the onset of AD-related dementia by inhibiting both AD-related neuronal cell death and dysfunction.

Citing Articles

Humanin-G Ameliorates Hemorrhage-Induced Acute Lung Injury in Mice Through AMPKα1-Dependent and -Independent Mechanisms.

Amman A, Wolfe V, Piraino G, Ziady A, Zingarelli B Biomedicines. 2024; 12(11).

PMID: 39595179 PMC: 11592305. DOI: 10.3390/biomedicines12112615.

The function of previously unappreciated exerkines secreted by muscle in regulation of neurodegenerative diseases.

Bian X, Wang Q, Wang Y, Lou S Front Mol Neurosci. 2024; 16:1305208.

PMID: 38249295 PMC: 10796786. DOI: 10.3389/fnmol.2023.1305208.

Mitochondrial-derived peptides: Antidiabetic functions and evolutionary perspectives.

Kal S, Mahata S, Jati S, Mahata S Peptides. 2023; 172:171147.

PMID: 38160808 PMC: 10838678. DOI: 10.1016/j.peptides.2023.171147.

Neuroprotective Action of Humanin and Humanin Analogues: Research Findings and Perspectives.

Karachaliou C, Livaniou E Biology (Basel). 2023; 12(12).

PMID: 38132360 PMC: 10740898. DOI: 10.3390/biology12121534.

Intercellular mitochondrial transfer in the brain, a new perspective for targeted treatment of central nervous system diseases.

Geng Z, Guan S, Wang S, Yu Z, Liu T, Du S CNS Neurosci Ther. 2023; 29(11):3121-3135.

PMID: 37424172 PMC: 10580346. DOI: 10.1111/cns.14344.

References

Haroutunian V, Schnaider-Beeri M, Schmeidler J, Wysocki M, Purohit D, Perl D . Role of the neuropathology of Alzheimer disease in dementia in the oldest-old. Arch Neurol. 2008; 65(9):1211-7. PMC: 3071251. DOI: 10.1001/archneur.65.9.1211. View

Tajima H, Niikura T, Hashimoto Y, Ito Y, Kita Y, Terashita K . Evidence for in vivo production of Humanin peptide, a neuroprotective factor against Alzheimer's disease-related insults. Neurosci Lett. 2002; 324(3):227-31. DOI: 10.1016/s0304-3940(02)00199-4. View

Davis S, Aldrich T, Stahl N, Pan L, Taga T, Kishimoto T . LIFR beta and gp130 as heterodimerizing signal transducers of the tripartite CNTF receptor. Science. 1993; 260(5115):1805-8. DOI: 10.1126/science.8390097. View

Selkoe D . Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior. Behav Brain Res. 2008; 192(1):106-13. PMC: 2601528. DOI: 10.1016/j.bbr.2008.02.016. View

Rogaev E, Sherrington R, Rogaeva E, Levesque G, Ikeda M, Liang Y . Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature. 1995; 376(6543):775-8. DOI: 10.1038/376775a0. View

Scheuner D, Eckman C, Jensen M, Song X, Citron M, Suzuki N . Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat Med. 1996; 2(8):864-70. DOI: 10.1038/nm0896-864. View

Derouet D, Rousseau F, Alfonsi F, Froger J, Hermann J, Barbier F . Neuropoietin, a new IL-6-related cytokine signaling through the ciliary neurotrophic factor receptor. Proc Natl Acad Sci U S A. 2004; 101(14):4827-32. PMC: 387333. DOI: 10.1073/pnas.0306178101. View

Pennanen C, Kivipelto M, Tuomainen S, Hartikainen P, Hanninen T, Laakso M . Hippocampus and entorhinal cortex in mild cognitive impairment and early AD. Neurobiol Aging. 2004; 25(3):303-10. DOI: 10.1016/S0197-4580(03)00084-8. View

Ewbank D, Arnold S . Cool with plaques and tangles. N Engl J Med. 2009; 360(22):2357-9. DOI: 10.1056/NEJMe0901965. View

10.

Taga T, Kishimoto T . Gp130 and the interleukin-6 family of cytokines. Annu Rev Immunol. 1997; 15:797-819. DOI: 10.1146/annurev.immunol.15.1.797. View

11.

Tajima H, Kawasumi M, Chiba T, Yamada M, Yamashita K, Nawa M . A humanin derivative, S14G-HN, prevents amyloid-beta-induced memory impairment in mice. J Neurosci Res. 2005; 79(5):714-23. DOI: 10.1002/jnr.20391. View

12.

Kariya S, Takahashi N, Ooba N, Kawahara M, Nakayama H, Ueno S . Humanin inhibits cell death of serum-deprived PC12h cells. Neuroreport. 2002; 13(6):903-7. DOI: 10.1097/00001756-200205070-00034. View

13.

Duara R, Loewenstein D, Potter E, Appel J, Greig M, Urs R . Medial temporal lobe atrophy on MRI scans and the diagnosis of Alzheimer disease. Neurology. 2008; 71(24):1986-92. PMC: 2676975. DOI: 10.1212/01.wnl.0000336925.79704.9f. View

14.

Killiany R, Gomez-Isla T, Moss M, Kikinis R, Sandor T, Jolesz F . Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease. Ann Neurol. 2000; 47(4):430-9. View

15.

Borchelt D, Thinakaran G, Eckman C, Lee M, Davenport F, Ratovitsky T . Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo. Neuron. 1996; 17(5):1005-13. DOI: 10.1016/s0896-6273(00)80230-5. View

16.

Selkoe D . Alzheimer's disease is a synaptic failure. Science. 2002; 298(5594):789-91. DOI: 10.1126/science.1074069. View

17.

Leow A, Yanovsky I, Parikshak N, Hua X, Lee S, Toga A . Alzheimer's disease neuroimaging initiative: a one-year follow up study using tensor-based morphometry correlating degenerative rates, biomarkers and cognition. Neuroimage. 2009; 45(3):645-55. PMC: 2696624. DOI: 10.1016/j.neuroimage.2009.01.004. View

18.

Lucas S, Ghilardi N, Li J, de Sauvage F . IL-27 regulates IL-12 responsiveness of naive CD4+ T cells through Stat1-dependent and -independent mechanisms. Proc Natl Acad Sci U S A. 2003; 100(25):15047-52. PMC: 299900. DOI: 10.1073/pnas.2536517100. View

19.

Yoshida H, Miyazaki Y, Yoshiyuki M . Regulation of immune responses by interleukin-27. Immunol Rev. 2009; 226:234-47. DOI: 10.1111/j.1600-065X.2008.00710.x. View

20.

Henneman W, Sluimer J, Barnes J, van der Flier W, Sluimer I, Fox N . Hippocampal atrophy rates in Alzheimer disease: added value over whole brain volume measures. Neurology. 2009; 72(11):999-1007. PMC: 2821835. DOI: 10.1212/01.wnl.0000344568.09360.31. View